A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

March 9 (Reuters) - Xenon Pharmaceuticals said on Monday its experimental epilepsy drug met the main goal of showing a statistically significant reduction in focal onset seizures in a late-stage trial ...

Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7 ...

Quality sleep is critical for people living with epilepsy to avoid triggering seizures. Poor sleep can affect seizures, memory, and more.

An old epilepsy drug for sleep apnoea has sharply reduced night‑time breathing pauses in a major European trial. Could ...

A new drug is transforming the lives of children born with a severe form of epilepsy, say doctors and families. Dravet syndrome can cause dozens of dangerous seizures a day and affects about one in ...

An experimental treatment reduces seizures and other symptoms in children with a type of epilepsy called Dravet syndrome.

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy.

Discover how ultra-early epilepsy surgeries transform the lives of children with drug-resistant seizures, preventing long-term brain damage.